Published in J Mol Biol on March 30, 2006
Concurrent nucleation of 16S folding and induced fit in 30S ribosome assembly. Nature (2008) 2.19
High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis. Nucleic Acids Res (2008) 1.78
Time-resolved RNA SHAPE chemistry: quantitative RNA structure analysis in one-second snapshots and at single-nucleotide resolution. Nat Protoc (2009) 1.60
RNA misfolding and the action of chaperones. Front Biosci (2008) 1.59
Tertiary interactions determine the accuracy of RNA folding. J Am Chem Soc (2008) 1.40
Semiautomated and rapid quantification of nucleic acid footprinting and structure mapping experiments. Nat Protoc (2008) 1.27
Distinct contribution of electrostatics, initial conformational ensemble, and macromolecular stability in RNA folding. Proc Natl Acad Sci U S A (2007) 1.26
Evaluation of the information content of RNA structure mapping data for secondary structure prediction. RNA (2010) 1.23
The Simbios National Center: Systems Biology in Motion. Proc IEEE Inst Electr Electron Eng (2008) 1.20
Evaluating our ability to predict the structural disruption of RNA by SNPs. BMC Genomics (2012) 1.19
Assembly mechanisms of RNA pseudoknots are determined by the stabilities of constituent secondary structures. Proc Natl Acad Sci U S A (2009) 1.16
Energy barriers, pathways, and dynamics during folding of large, multidomain RNAs. Curr Opin Chem Biol (2008) 1.15
The structural dynamics of macromolecular processes. Curr Opin Cell Biol (2009) 1.12
Unwinding RNA's secrets: advances in the biology, physics, and modeling of complex RNAs. Curr Opin Struct Biol (2008) 1.10
Deletion of the P5abc peripheral element accelerates early and late folding steps of the Tetrahymena group I ribozyme. Biochemistry (2007) 0.98
Self-splicing of a group I intron reveals partitioning of native and misfolded RNA populations in yeast. RNA (2006) 0.92
Multiple unfolding events during native folding of the Tetrahymena group I ribozyme. J Mol Biol (2010) 0.91
RNA molecules with conserved catalytic cores but variable peripheries fold along unique energetically optimized pathways. RNA (2011) 0.91
Evolutionary evidence for alternative structure in RNA sequence co-variation. PLoS Comput Biol (2013) 0.91
Complementing global measures of RNA folding with local reports of backbone solvent accessibility by time resolved hydroxyl radical footprinting. Methods (2009) 0.85
Informatics challenges in structured RNA. Brief Bioinform (2007) 0.85
Understanding the role of three-dimensional topology in determining the folding intermediates of group I introns. Biophys J (2013) 0.80
Communication between RNA folding domains revealed by folding of circularly permuted ribozymes. J Mol Biol (2007) 0.80
Exhaustive Enumeration of Kinetic Model Topologies for the Analysis of Time-Resolved RNA Folding. Algorithms (2009) 0.79
RNA catalysis as a probe for chaperone activity of DEAD-box helicases. Methods Enzymol (2012) 0.78
Mapping the kinetic barriers of a Large RNA molecule's folding landscape. PLoS One (2014) 0.77
RNA does the folding dance of twist, turn, stack. Proc Natl Acad Sci U S A (2013) 0.76
Nucleobases Undergo Dynamic Rearrangements during RNA Tertiary Folding. J Mol Biol (2016) 0.75
Crystal structure of a group I ribozyme domain: principles of RNA packing. Science (1996) 13.99
SAFA: semi-automated footprinting analysis software for high-throughput quantification of nucleic acid footprinting experiments. RNA (2005) 3.95
Defining the inside and outside of a catalytic RNA molecule. Science (1989) 3.82
RNA folding at millisecond intervals by synchrotron hydroxyl radical footprinting. Science (1998) 3.67
Quantitative DNase footprint titration: a method for studying protein-DNA interactions. Methods Enzymol (1986) 3.36
Visualizing the higher order folding of a catalytic RNA molecule. Science (1991) 3.19
Tertiary Motifs in RNA Structure and Folding. Angew Chem Int Ed Engl (1999) 3.15
Kinetic intermediates in RNA folding. Science (1994) 3.07
New loop-loop tertiary interactions in self-splicing introns of subgroup IC and ID: a complete 3D model of the Tetrahymena thermophila ribozyme. Chem Biol (1996) 2.81
Exploring the folding landscape of a structured RNA. Proc Natl Acad Sci U S A (2001) 2.78
Strategies for RNA folding and assembly. Nat Rev Mol Cell Biol (2004) 2.59
Hydrogen exchange methods to study protein folding. Methods (2004) 2.47
RNA and protein folding: common themes and variations. Biochemistry (2005) 2.47
"Footprint" titrations yield valid thermodynamic isotherms. Proc Natl Acad Sci U S A (1986) 2.35
The kinetic folding pathway of the Tetrahymena ribozyme reveals possible similarities between RNA and protein folding. Nat Struct Biol (1996) 2.26
Folding of RNA involves parallel pathways. J Mol Biol (1997) 2.22
Single-molecule RNA science. Annu Rev Biophys Biomol Struct (2005) 1.93
Recent insights on RNA folding mechanisms from catalytic RNA. Cell Mol Life Sci (2000) 1.87
Probing the folding landscape of the Tetrahymena ribozyme: commitment to form the native conformation is late in the folding pathway. J Mol Biol (2001) 1.80
Role of counterion condensation in folding of the Tetrahymena ribozyme. I. Equilibrium stabilization by cations. J Mol Biol (2001) 1.78
Probing the structural dynamics of nucleic acids by quantitative time-resolved and equilibrium hydroxyl radical "footprinting". Curr Opin Struct Biol (2002) 1.73
Fast folding mutants of the Tetrahymena group I ribozyme reveal a rugged folding energy landscape. J Mol Biol (1998) 1.66
Ribozyme structures and mechanisms. Annu Rev Biophys Biomol Struct (2001) 1.62
Role of counterion condensation in folding of the Tetrahymena ribozyme. II. Counterion-dependence of folding kinetics. J Mol Biol (2001) 1.61
Time-resolved synchrotron X-ray "footprinting", a new approach to the study of nucleic acid structure and function: application to protein-DNA interactions and RNA folding. J Mol Biol (1997) 1.60
Folding mechanism of the Tetrahymena ribozyme P4-P6 domain. Biochemistry (2000) 1.56
An optimal Mg(2+) concentration for kinetic folding of the tetrahymena ribozyme. Proc Natl Acad Sci U S A (1999) 1.53
Iron(II)-ethylenediaminetetraacetic acid catalyzed cleavage of RNA and DNA oligonucleotides: similar reactivity toward single- and double-stranded forms. Biochemistry (1990) 1.47
Following the folding of RNA with time-resolved synchrotron X-ray footprinting. Methods Enzymol (1998) 1.43
Monovalent cations mediate formation of native tertiary structure of the Tetrahymena thermophila ribozyme. Nat Struct Biol (2002) 1.36
Real-time characterization of intermediates in the pathway to open complex formation by Escherichia coli RNA polymerase at the T7A1 promoter. Proc Natl Acad Sci U S A (2005) 1.36
Linkage of monovalent and divalent ion binding in the folding of the P4-P6 domain of the Tetrahymena ribozyme. Biochemistry (2002) 1.31
Folding mechanisms of group I ribozymes: role of stability and contact order. Biochem Soc Trans (2002) 1.29
Monovalent ion-mediated folding of the Tetrahymena thermophila ribozyme. J Mol Biol (2004) 1.24
In the fluorescent spotlight: global and local conformational changes of small catalytic RNAs. Biopolymers (2002) 1.22
NMR chemical shift perturbation study of the N-terminal domain of Hsp90 upon binding of ADP, AMP-PNP, geldanamycin, and radicicol. Chembiochem (2003) 1.20
Semi-automated, single-band peak-fitting analysis of hydroxyl radical nucleic acid footprint autoradiograms for the quantitative analysis of transitions. Nucleic Acids Res (2004) 1.10
Multiple monovalent ion-dependent pathways for the folding of the L-21 Tetrahymena thermophila ribozyme. J Mol Biol (2003) 1.02
Cooperativity, smooth energy landscapes and the origins of topology-dependent protein folding rates. J Mol Biol (2003) 0.98
On the theory of folding kinetics for short proteins. Fold Des (1997) 0.96
Extending the folding nucleus of ubiquitin with an independently folding beta-hairpin finger: hurdles to rapid folding arising from the stabilisation of local interactions. J Mol Biol (2005) 0.88
Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32
Clinical assessment incorporating a personal genome. Lancet (2010) 10.18
The chemical genomic portrait of yeast: uncovering a phenotype for all genes. Science (2008) 8.52
The incidentalome: a threat to genomic medicine. JAMA (2006) 7.24
Genetics. Genomic research and human subject privacy. Science (2004) 6.56
PharmGKB: the Pharmacogenetics Knowledge Base. Nucleic Acids Res (2002) 6.40
A Bayesian framework for combining heterogeneous data sources for gene function prediction (in Saccharomyces cerevisiae). Proc Natl Acad Sci U S A (2003) 6.19
From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource. Biomark Med (2011) 4.05
Knowledge acquisition, consistency checking and concurrency control for Gene Ontology (GO). Bioinformatics (2003) 3.97
SAFA: semi-automated footprinting analysis software for high-throughput quantification of nucleic acid footprinting experiments. RNA (2005) 3.95
Associating genes with gene ontology codes using a maximum entropy analysis of biomedical literature. Genome Res (2002) 3.77
Nonparametric methods for identifying differentially expressed genes in microarray data. Bioinformatics (2002) 3.65
Health-information altruists--a potentially critical resource. N Engl J Med (2005) 3.61
The RNA Ontology Consortium: an open invitation to the RNA community. RNA (2006) 3.60
Creating an online dictionary of abbreviations from MEDLINE. J Am Med Inform Assoc (2002) 3.32
Genetic variants associated with warfarin dose in African-American individuals: a genome-wide association study. Lancet (2013) 3.21
Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20
Data-driven prediction of drug effects and interactions. Sci Transl Med (2012) 2.93
Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92
Eukaryotic regulatory element conservation analysis and identification using comparative genomics. Genome Res (2004) 2.84
PharmGKB: a logical home for knowledge relating genotype to drug response phenotype. Nat Genet (2007) 2.65
Coarse-grained modeling of large RNA molecules with knowledge-based potentials and structural filters. RNA (2009) 2.63
A novel signal detection algorithm for identifying hidden drug-drug interactions in adverse event reports. J Am Med Inform Assoc (2011) 2.53
Clinical implementation of pharmacogenomics: overcoming genetic exceptionalism. Lancet Oncol (2010) 2.52
The pharmacogenetics and pharmacogenomics knowledge base: accentuating the knowledge. Nucleic Acids Res (2007) 2.45
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Bioinformatics challenges for personalized medicine. Bioinformatics (2011) 2.28
Time to organize the bioinformatics resourceome. PLoS Comput Biol (2005) 2.25
MScanner: a classifier for retrieving Medline citations. BMC Bioinformatics (2008) 2.24
Using binning to maintain confidentiality of medical data. Proc AMIA Symp (2002) 2.23
Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc (2013) 2.19
Using text to build semantic networks for pharmacogenomics. J Biomed Inform (2010) 2.19
Pharmspresso: a text mining tool for extraction of pharmacogenomic concepts and relationships from full text. BMC Bioinformatics (2009) 2.15
PharmGKB: understanding the effects of individual genetic variants. Drug Metab Rev (2008) 2.09
GAPSCORE: finding gene and protein names one word at a time. Bioinformatics (2004) 2.05
Pharmacogenomics: challenges and opportunities. Ann Intern Med (2006) 1.96
Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery. Genome Res (2004) 1.92
Pharmacogenomics and bioinformatics: PharmGKB. Pharmacogenomics (2010) 1.91
Principles of RNA compaction: insights from the equilibrium folding pathway of the P4-P6 RNA domain in monovalent cations. J Mol Biol (2004) 1.90
Recent progress in automatically extracting information from the pharmacogenomic literature. Pharmacogenomics (2010) 1.88
Automating data acquisition into ontologies from pharmacogenetics relational data sources using declarative object definitions and XML. Pac Symp Biocomput (2002) 1.81
PharmGKB: the Pharmacogenomics Knowledge Base. Methods Mol Biol (2013) 1.81
PharmGKB: the pharmacogenetics and pharmacogenomics knowledge base. Methods Mol Biol (2005) 1.80
High-throughput single-nucleotide structural mapping by capillary automated footprinting analysis. Nucleic Acids Res (2008) 1.78
Using text analysis to identify functionally coherent gene groups. Genome Res (2002) 1.71
The FEATURE framework for protein function annotation: modeling new functions, improving performance, and extending to novel applications. BMC Genomics (2008) 1.64
Finding haplotype tagging SNPs by use of principal components analysis. Am J Hum Genet (2004) 1.61
MutDB: annotating human variation with functionally relevant data. Bioinformatics (2003) 1.54
Structural inference of native and partially folded RNA by high-throughput contact mapping. Proc Natl Acad Sci U S A (2008) 1.54
Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics (2011) 1.53
Discovery and explanation of drug-drug interactions via text mining. Pac Symp Biocomput (2012) 1.53
Training the next generation of informaticians: the impact of "BISTI" and bioinformatics--a report from the American College of Medical Informatics. J Am Med Inform Assoc (2004) 1.53
Concerted binding and bending of DNA by Escherichia coli integration host factor. J Mol Biol (2002) 1.49
The computational analysis of scientific literature to define and recognize gene expression clusters. Nucleic Acids Res (2003) 1.44
Independent component analysis: mining microarray data for fundamental human gene expression modules. J Biomed Inform (2010) 1.39
Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics (2012) 1.38
A statistical approach to scanning the biomedical literature for pharmacogenetics knowledge. J Am Med Inform Assoc (2004) 1.37
Monovalent cations mediate formation of native tertiary structure of the Tetrahymena thermophila ribozyme. Nat Struct Biol (2002) 1.36
WebFEATURE: An interactive web tool for identifying and visualizing functional sites on macromolecular structures. Nucleic Acids Res (2003) 1.35
Fast Fenton footprinting: a laboratory-based method for the time-resolved analysis of DNA, RNA and proteins. Nucleic Acids Res (2006) 1.33
Concordant exploration of the kinetics of RNA folding from global and local perspectives. J Mol Biol (2005) 1.33
A literature-based method for assessing the functional coherence of a gene group. Bioinformatics (2003) 1.33
Linkage of monovalent and divalent ion binding in the folding of the P4-P6 domain of the Tetrahymena ribozyme. Biochemistry (2002) 1.31
A call for the creation of personalized medicine databases. Nat Rev Drug Discov (2006) 1.30
Extracting and characterizing gene-drug relationships from the literature. Pharmacogenetics (2004) 1.30
Using ODIN for a PharmGKB revalidation experiment. Database (Oxford) (2012) 1.29
Integration and publication of heterogeneous text-mined relationships on the Semantic Web. J Biomed Semantics (2011) 1.29
Biomedical term mapping databases. Nucleic Acids Res (2005) 1.29
Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein). Pharmacogenet Genomics (2011) 1.29
Informatics confronts drug-drug interactions. Trends Pharmacol Sci (2013) 1.28
Turning limited experimental information into 3D models of RNA. RNA (2010) 1.27
Semiautomated and rapid quantification of nucleic acid footprinting and structure mapping experiments. Nat Protoc (2008) 1.27
A new disease-specific machine learning approach for the prediction of cancer-causing missense variants. Genomics (2011) 1.27
PharmGKB summary: methotrexate pathway. Pharmacogenet Genomics (2011) 1.27
Distinct contribution of electrostatics, initial conformational ensemble, and macromolecular stability in RNA folding. Proc Natl Acad Sci U S A (2007) 1.26
Pharmacogenomics: The relevance of emerging genotyping technologies. MLO Med Lab Obs (2006) 1.26
Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control. Genes Dev (2012) 1.26
Productive folding to the native state by a group II intron ribozyme. J Mol Biol (2002) 1.26
Large scale study of protein domain distribution in the context of alternative splicing. Nucleic Acids Res (2003) 1.26
Predicting drug side-effects by chemical systems biology. Genome Biol (2009) 1.26
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 19. Pharmacogenet Genomics (2012) 1.25
Monovalent ion-mediated folding of the Tetrahymena thermophila ribozyme. J Mol Biol (2004) 1.24
An alternative route for the folding of large RNAs: apparent two-state folding by a group II intron ribozyme. J Mol Biol (2003) 1.24
Robust recognition of zinc binding sites in proteins. Protein Sci (2007) 1.23
Tools for loading MEDLINE into a local relational database. BMC Bioinformatics (2004) 1.23
Using Petri Net tools to study properties and dynamics of biological systems. J Am Med Inform Assoc (2004) 1.23
Extracting subject demographic information from abstracts of randomized clinical trial reports. Stud Health Technol Inform (2007) 1.22
Cytochrome P450 2D6. Pharmacogenet Genomics (2009) 1.22
The Simbios National Center: Systems Biology in Motion. Proc IEEE Inst Electr Electron Eng (2008) 1.20
Collective judgment predicts disease-associated single nucleotide variants. BMC Genomics (2013) 1.20
Improving the prediction of disease-related variants using protein three-dimensional structure. BMC Bioinformatics (2011) 1.20
Snf2/Swi2-related ATPase Mot1 drives displacement of TATA-binding protein by gripping DNA. EMBO J (2006) 1.18
Cooperative transcription factor associations discovered using regulatory variation. Proc Natl Acad Sci U S A (2011) 1.18
Hinge stiffness is a barrier to RNA folding. J Mol Biol (2008) 1.17
PharmGKB summary: fluoropyrimidine pathways. Pharmacogenet Genomics (2011) 1.16